Geron Corporation Sustainability Profile
Geron Corporation, a pioneering biotechnology firm headquartered in the United States, focuses on developing innovative therapies for cancer and other serious diseases. Founded in 1990, Geron has made significant strides in the field of telomerase biology, positioning itself as a leader in the development of telomerase inhibitors. The company’s flagship product, imetelstat, is a first-in-class telomerase inhibitor that targets cancer stem cells, offering a unique approach to treating various malignancies. Geron’s commitment to advancing cancer treatment has garnered attention within the industry, as it continues to explore new therapeutic avenues and expand its operational reach. With a strong emphasis on research and development, Geron Corporation remains at the forefront of biopharmaceutical innovation, striving to improve patient outcomes in oncology.
DitchCarbon Score
How does Geron Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Geron Corporation's score of 25 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Geron Corporation's reported carbon emissions
Geron Corporation, headquartered in the US, currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their total emissions, including Scope 1, Scope 2, and Scope 3, are not provided. Additionally, there are no documented reduction targets or climate pledges from Geron Corporation at this time. The absence of these commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the context of the industry, many organisations are increasingly adopting science-based targets and sustainability initiatives to mitigate their carbon footprints. However, without specific data or commitments from Geron Corporation, it is unclear how they align with these industry standards.
How Carbon Intensive is Geron Corporation's Industry?
How Carbon Intensive is Geron Corporation's Location?
Geron Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Geron Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Regenerative Sciences, Inc.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.